Metraipolis › archive › dc_28d08f376b96
Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities — Europe PMC PMID:42279327
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42279327
- DOI
- 10.3390/cancers18111744
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T05:48:48.458Z
- SHA-256 of the archived text
e353bd24691f5d759c9936d40c0057742518740dd46b574c02ed959e43260e43- Stable URL of this page
https://metraipolis.com/documento/dc_28d08f376b96
How to cite
Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities — Europe PMC PMID:42279327 — Europe PMC (en), https://europepmc.org/article/MED/42279327 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28d08f376b96 (Metraipolis archive dc_28d08f376b96, sha256 e353bd24691f5d759c9936d40c0057742518740dd46b574c02ed959e43260e43)
BibTeX
@misc{dc28d08f376b96,
title = {Functional Precision Oncology in Fibrolamellar Carcinoma: Ex Vivo Identification of Therapeutic Vulnerabilities — Europe PMC PMID:42279327},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42279327},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28d08f376b96; sha256 e353bd24691f5d759c9936d40c0057742518740dd46b574c02ed959e43260e43},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279327. Agents can read the archived copy with the MCP tool read_document.